You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

Article metrics

Article menu

Download PDFPDF

Immunotherapy biomarkers
Original research
DNA methylation profiles differ in responders versus non-responders to anti-PD-1 immune checkpoint inhibitors in patients with advanced and metastatic head and neck squamous cell carcinoma

 

Online download statistics by month:

Online download statistics by month: March 2022 to September 2025

AbstractFullPdf
Mar 2022501528170
Apr 2022296311164
May 202221723196
Jun 202222523080
Jul 202216416562
Aug 202219520163
Sep 202215616070
Oct 202219419865
Nov 202212012452
Dec 202210310628
Jan 2023788030
Feb 2023828532
Mar 2023434626
Apr 2023717128
May 2023444422
Jun 2023454619
Jul 2023384226
Aug 2023383919
Sep 2023363721
Oct 2023505023
Nov 2023404023
Dec 2023535424
Jan 2024373733
Feb 2024535426
Mar 20246161131
Apr 2024525547
May 2024444620
Jun 2024404519
Jul 2024585834
Aug 2024323115
Sep 2024424322
Oct 2024464743
Nov 2024626559
Dec 2024838541
Jan 2025464731
Feb 2025393925
Mar 2025404030
Apr 2025535317
May 2025515133
Jun 2025282825
Jul 2025110
Sep 2025110
Total365837751794